301 related articles for article (PubMed ID: 6607655)
1. Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent.
Weinmann HJ; Brasch RC; Press WR; Wesbey GE
AJR Am J Roentgenol; 1984 Mar; 142(3):619-24. PubMed ID: 6607655
[TBL] [Abstract][Full Text] [Related]
2. [A comparative study between Gd-BOPTA, a biliary excretion contrast medium, and Gd-DTPA in the magnetic resonance imaging of the rat liver].
Patrizio G; Pavone P; Cardone G; Pietroletti R; Passariello R; Tettamanti E; Musu C; Felder E
Radiol Med; 1990 May; 79(5):458-62. PubMed ID: 2359853
[TBL] [Abstract][Full Text] [Related]
3. Contrast-enhanced NMR imaging: animal studies using gadolinium-DTPA complex.
Brasch RC; Weinmann HJ; Wesbey GE
AJR Am J Roentgenol; 1984 Mar; 142(3):625-30. PubMed ID: 6607656
[TBL] [Abstract][Full Text] [Related]
4. Gadolinium-DTPA: a new contrast agent for magnetic resonance imaging.
Niendorf HP; Felix R; Laniado M; Schörner W; Claussen C; Weinmann HJ
Radiat Med; 1985; 3(1):7-12. PubMed ID: 4070676
[TBL] [Abstract][Full Text] [Related]
5. Use of gadolinium-DTPA as a myocardial perfusion agent: potential applications and limitations for magnetic resonance imaging.
Johnston DL; Liu P; Lauffer RB; Newell JB; Wedeen VJ; Rosen BR; Brady TJ; Okada RD
J Nucl Med; 1987 May; 28(5):871-7. PubMed ID: 3572546
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging of local soft tissue inflammation using gadolinium-DTPA.
Paajanen H; Brasch RC; Schmiedl U; Ogan M
Acta Radiol; 1987; 28(1):79-83. PubMed ID: 2952148
[TBL] [Abstract][Full Text] [Related]
7. Whole-body autoradiographic studies in rats with gadolinium-diethylenetriaminepentaacetic acid, a new contrast agent for magnetic resonance imaging.
Täuber U; Weinmann HJ; Panzer M; Acksteiner B; Vollert B; Schulze PE
Arzneimittelforschung; 1986 Jul; 36(7):1089-91. PubMed ID: 3768078
[TBL] [Abstract][Full Text] [Related]
8. [Nuclear magnetic resonance imaging of uterine cancer with and without the administration of the paramagnetic contrast medium Gd-DTPA].
Roth G; Sundermeyer R
Geburtshilfe Frauenheilkd; 1986 Nov; 46(11):790-5. PubMed ID: 3803872
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the contrast-enhancing properties of albumin-(Gd-DTPA) and Gd-DTPA at 2.0 T: and experimental study in rats.
Schmiedl U; Ogan MD; Moseley ME; Brasch RC
AJR Am J Roentgenol; 1986 Dec; 147(6):1263-70. PubMed ID: 3535459
[TBL] [Abstract][Full Text] [Related]
10. Gadolinium-DTPA enhancement of experimental soft tissue carcinoma and hemorrhage in magnetic resonance imaging.
Pettersson H; Ackerman N; Kaude J; Googe RE; Mancuso AA; Scott KN; Hackett RH; Hager DA; Caballero S
Acta Radiol; 1987; 28(1):75-8. PubMed ID: 2952147
[TBL] [Abstract][Full Text] [Related]
11. First use of GdDTPA/dimeglumine in man.
Laniado M; Weinmann HJ; Schörner W; Felix R; Speck U
Physiol Chem Phys Med NMR; 1984; 16(2):157-65. PubMed ID: 6505042
[TBL] [Abstract][Full Text] [Related]
12. Albumin labeled with Gd-DTPA. An intravascular contrast-enhancing agent for magnetic resonance blood pool imaging: preparation and characterization.
Ogan MD; Schmiedl U; Moseley ME; Grodd W; Paajanen H; Brasch RC
Invest Radiol; 1987 Aug; 22(8):665-71. PubMed ID: 3667174
[TBL] [Abstract][Full Text] [Related]
13. Gadolinium-ethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent. Kinetic and enhancement patterns in normal and cholestatic rats.
Clément O; Mühler A; Vexler V; Berthezène Y; Brasch RC
Invest Radiol; 1992 Aug; 27(8):612-9. PubMed ID: 1428739
[TBL] [Abstract][Full Text] [Related]
14. Gadolinium DTPA (an NMR proton imaging contrast agent): chemical structure, paramagnetic properties and pharmacokinetics.
Goldstein EJ; Burnett KR; Hansell JR; Casaia J; Dizon J; Farrar B; Gelblum D; Wolf GL
Physiol Chem Phys Med NMR; 1984; 16(2):97-104. PubMed ID: 6095342
[TBL] [Abstract][Full Text] [Related]
15. Lanthanide chelates of (bis)-hydroxymethyl-substituted DTTA with potential application as contrast agents in magnetic resonance imaging.
Silvério S; Torres S; Martins AF; Martins JA; André JP; Helm L; Prata MI; Santos AC; Geraldes CF
Dalton Trans; 2009 Jun; (24):4656-70. PubMed ID: 19513474
[TBL] [Abstract][Full Text] [Related]
16. [Contrast media in magnetic resonance tomography. A review. 1. Physicochemical and pharmacological bases of MR contrast media using gadolinium-DTPA as an example].
Felix R; Semmler W; Schörner W; Laniado M
Rofo; 1985 Jun; 142(6):641-6. PubMed ID: 2988062
[TBL] [Abstract][Full Text] [Related]
17. Some aspects of the use of contrast agents in magnetic resonance imaging.
Niendorf HP; Semmler W; Laniado M; Felix R
Diagn Imaging Clin Med; 1986; 55(1-2):25-36. PubMed ID: 3011346
[TBL] [Abstract][Full Text] [Related]
18. [Human testing of the nuclear spin tomographic contrast medium gadolinium-DTPA. Tolerance, contrast affect and the 1st clinical results].
Schörner W; Felix R; Laniado M; Lange L; Weinmann HJ; Claussen C; Fiegler W; Speck U; Kazner E
Rofo; 1984 May; 140(5):493-500. PubMed ID: 6429753
[TBL] [Abstract][Full Text] [Related]
19. Acute experimental cerebral ischemia: MR enhancement using Gd-DTPA.
McNamara MT; Brant-Zawadzki M; Berry I; Pereira B; Weinstein P; Derugin N; Moore S; Kucharczyk W; Brasch RC
Radiology; 1986 Mar; 158(3):701-5. PubMed ID: 3945743
[TBL] [Abstract][Full Text] [Related]
20. [Preclinical investigation of Mn(II)-diethylenetriaminepentaacetate (Mangapentetate) as paramagnetic contrast agent for magnetic resonance tomography].
Usov VIu; Belianin ML; Karpova GV; Borodin OIu; Filimonov VD
Eksp Klin Farmakol; 2008; 71(4):41-6; discussion 47-8. PubMed ID: 18819440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
